Alzheimer’s Disease Neuroimaging Initiative Private Partner Scientific Board (ADNI-PPSB)
Background
The ADNI-PPSB serves as an independent, open, and pre-competitive forum in which all private sector and not-for-profit partners in the ADNI can collaborate, share information, and offer scientific and private-sector perspectives and expertise on issues relating to ADNI.
"Our goal in convening the ADNI-PPSB is to provide global industry experts a platform to collaborate, and allow for projects to emerge and crystallize from ADNI-PPSB members."
Chris Weber, Senior Director, Global Science Initiatives, Alzheimer's Association
The ADNI-PPSB has several opportunities to get involved, including:
- ADNI PET Endpoints workgroup
- ADNI Engagement workgroup
- ADNI Biomarkers & Biofluids workgroup
- ADNI Clinical Endpoints workgroup
Alzheimer’s Disease Neuroimaging Initiative
ADNI, a landmark partnership and study that for years has profoundly influenced our understanding of Alzheimer’s disease (AD), is identifying the earliest changes in brain structure and function that signal its onset and progression of AD.
The study is fully funded by the National Institute on Aging. Since the launch of ADNI1 in 2004, ADNI has gone through several peer-reviewed renewals, with ADNI-GO and ADNI2 in 2014. ADNI3 partnership and study was launched in 2016. The current grant for ADNI4 is a five-year extension of the study, which began in September 2022.
Partners
Get involved
If companies are interested in learning more about the ADNI-PPSB and the workgroups available, please contact:
Chris Weber
Senior Director, Global Science Initiatives
cweber@alz.org
Corporate Initiatives Team
corporateinitiatives@alz.org